Simonsen O, Schou C, Heron I
J Biol Stand. 1987 Apr;15(2):143-57. doi: 10.1016/0092-1157(87)90037-0.
The use of indirect ELISA for the quantitation of tetanus toxin neutralizing antibodies in human sera is limited by marked overestimations in low titered sera. The reasons for the discrepancy between the results obtained by ELISA and by in vivo assay and modifications of the ELISA to overcome the problem were investigated. Catching ELISA and indirect ELISA using trays coated with the contaminant proteins in toxoid preparations indicated that antibodies to contaminants were only partly responsible for the discrepancy and the introduction of these modifications did not solve the problem. In ELISA competition experiments with toxin neutralizing monoclonal antibodies, the human immunoglobulins irrelevant in toxin neutralization, but detectable in indirect ELISA, were found to be difficult to inhibit in their binding to the solid antigen phase. These might represent antitoxins bound bivalently to the solid phase but with affinities in monovalent binding insufficient for toxin neutralization or other coupled antibodies due to conformational changes of the antigen. A competition ELISA with toxin in solution was therefore developed to assess selectively the antitoxin capable of binding the antigen in solution and by this approach the in vivo activities of even low titered sera were accurately predicted. This antigen competition ELISA may be easily introduced into routine tetanus serology and the principle may also be of value for the in vitro detection of functional antibodies to other antigens.
间接酶联免疫吸附测定法(ELISA)用于定量检测人血清中破伤风毒素中和抗体时,存在对低滴度血清明显高估的问题,其应用受到限制。研究了ELISA法与体内试验结果存在差异的原因以及对ELISA法进行改进以克服该问题。采用类毒素制剂中污染蛋白包被的酶标板进行捕获ELISA和间接ELISA,结果表明针对污染物的抗体只是造成差异的部分原因,引入这些改进措施并不能解决问题。在与毒素中和单克隆抗体进行的ELISA竞争实验中,发现那些在毒素中和中无关但在间接ELISA中可检测到的人免疫球蛋白,难以抑制其与固相抗原的结合。这些可能代表了以二价形式结合到固相上但单价结合亲和力不足以中和毒素的抗毒素,或者是由于抗原构象变化而产生的其他偶联抗体。因此,开发了一种在溶液中加入毒素的竞争ELISA法,以选择性地评估能够结合溶液中抗原的抗毒素,通过这种方法可以准确预测即使是低滴度血清的体内活性。这种抗原竞争ELISA法可轻松引入常规破伤风血清学检测中,其原理对于体外检测针对其他抗原的功能性抗体也可能具有价值。